The Unexpected Risks of COVID-19 on Asthma Control in Children.


Journal

The journal of allergy and clinical immunology. In practice
ISSN: 2213-2201
Titre abrégé: J Allergy Clin Immunol Pract
Pays: United States
ID NLM: 101597220

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 05 05 2020
revised: 26 05 2020
accepted: 27 05 2020
pubmed: 5 6 2020
medline: 18 9 2020
entrez: 5 6 2020
Statut: ppublish

Résumé

Much is being learned about clinical outcomes for adult COVID-19 patients with underlying chronic conditions; however, there is less coverage on how the COVID-19 pandemic impacts the management of chronic medical conditions, such as asthma, in children and youth. Asthma is a common chronic medical condition in children that is uniquely susceptible to changes brought on by COVID-19. Sudden dramatic changes in the environment, medical practice, and medication use have altered the asthma management landscape with potential impacts on asthma outcomes. In this paper, we review how changes in transportation and travel patterns, school attendance, physical activity, and time spent indoors, along with changes in health care delivery since the start of the pandemic, all play a contributing role in asthma control in children. We review potentially important influences of asthma control in children during the COVID-19 pandemic worthy of further study.

Identifiants

pubmed: 32497662
pii: S2213-2198(20)30523-7
doi: 10.1016/j.jaip.2020.05.027
pmc: PMC7263244
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2489-2491

Informations de copyright

Copyright © 2020 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Références

JAMA. 2001 Feb 21;285(7):897-905
pubmed: 11180733
Pediatrics. 2009 Mar;123 Suppl 3:S131-45
pubmed: 19221156
Clin Infect Dis. 2020 Jul 28;71(15):799-806
pubmed: 32271376
J Infect. 2020 Jul;81(1):e13-e20
pubmed: 32283144

Auteurs

Nicolas M Oreskovic (NM)

Department of Pediatrics, Massachusetts General Hospital, Boston, Mass; Department of Internal Medicine, Massachusetts General Hospital, Boston, Mass; Department of Pediatrics, Harvard Medical School, Boston, Mass. Electronic address: noreskovic@mgh.harvard.edu.

T Bernard Kinane (TB)

Department of Pediatrics, Massachusetts General Hospital, Boston, Mass; Department of Pediatrics, Harvard Medical School, Boston, Mass.

Emmanuel Aryee (E)

Department of Pediatrics, Massachusetts General Hospital, Boston, Mass.

Karen A Kuhlthau (KA)

Department of Pediatrics, Massachusetts General Hospital, Boston, Mass; Department of Pediatrics, Harvard Medical School, Boston, Mass.

James M Perrin (JM)

Department of Pediatrics, Massachusetts General Hospital, Boston, Mass; Department of Pediatrics, Harvard Medical School, Boston, Mass.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH